Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden · Delayed Price · Currency is SEK 2.850
-0.110 (-3.72%)
At close: Feb 26, 2026
Bio-Works Technologies AB Employees
Bio-Works Technologies AB had 29 employees as of September 30, 2025. The number of employees decreased by 6 or -17.14% compared to the same quarter last year.
Employees
29
Change
-6
Growth
-17.14%
Revenue / Employee
2.43M SEK
Profits / Employee
-586.42K SEK
Market Cap
294.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 29 | -6 | -17.14% |
| Jun 30, 2025 | 29 | -6 | -17.14% |
| Mar 31, 2025 | 29 | -7 | -19.22% |
| Dec 31, 2024 | 30 | -6 | -16.43% |
| Sep 30, 2024 | 35 | -1 | -2.51% |
| Dec 31, 2023 | 36 | -9 | -20.40% |
| Dec 31, 2022 | 45 | 9 | 24.24% |
| Dec 31, 2021 | 36 | 10 | 35.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncopeptides AB | 75 |
| Sprint Bioscience AB | 29 |
| Mendus AB | 20 |
| Intervacc AB | 15 |
| Xintela AB | 13 |
| Corline Biomedical AB | 13 |
| AlzeCure Pharma AB | 11 |
| Ascelia Pharma AB | 11 |